Research in the Cheng laboratory is focused on the development of quantitative magnetic resonance imaging technology to enable advances in tissue engineering and other emerging therapies, and to achieve earlier detection of cardiovascular diseases and cancer than is currently possible. We take imaging beyond its role as an anatomical tool and advance it to probe physiological, cellular, and molecular events. An important philosophy at the heart of our research is translation to patients – hence, our emphasis on clinical platforms, rapid imaging, and safety. Our technology-driven program is intimately tied to biology-directed questions in in-vivo models to gain new insight into disease development and to develop better diagnostic and therapeutic tools.